Shuttle Pharmaceuticals Statistics
Share Statistics
Shuttle Pharmaceuticals has 3.66M shares outstanding. The number of shares has increased by -81.59% in one year.
| Shares Outstanding | 3.66M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -82.46% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 2.74M |
| Failed to Deliver (FTD) Shares | 20 |
| FTD / Avg. Volume | 0% |
Short Selling Information
The latest short interest is 702.63K, so 19.17% of the outstanding shares have been sold short.
| Short Interest | 702.63K |
| Short % of Shares Out | 19.17% |
| Short % of Float | 27.94% |
| Short Ratio (days to cover) | 0.25 |
Valuation Ratios
The PE ratio is -8.78 and the forward PE ratio is null.
| PE Ratio | -8.78 |
| Forward PE | null |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 14.28 |
| P/FCF Ratio | -10.34 |
| PEG Ratio | n/a |
Enterprise Valuation
Shuttle Pharmaceuticals Inc. has an Enterprise Value (EV) of -.
| EV / Earnings | null |
| EV / Sales | null |
| EV / EBITDA | null |
| EV / EBIT | null |
| EV / FCF | null |
Financial Position
The company has a current ratio of 5.37, with a Debt / Equity ratio of 0.19.
| Current Ratio | 5.37 |
| Quick Ratio | 5.37 |
| Debt / Equity | 0.19 |
| Total Debt / Capitalization | 16.19 |
| Cash Flow / Debt | -7.12 |
| Interest Coverage | -2.27 |
Financial Efficiency
Return on equity (ROE) is -1.63% and return on capital (ROIC) is -114.56%.
| Return on Equity (ROE) | -1.63% |
| Return on Assets (ROA) | -1.11% |
| Return on Capital (ROIC) | -114.56% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -824.09K |
| Employee Count | 8 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -82.2% in the last 52 weeks. The beta is 0.74, so Shuttle Pharmaceuticals 's price volatility has been higher than the market average.
| Beta | 0.74 |
| 52-Week Price Change | -82.2% |
| 50-Day Moving Average | 1.11 |
| 200-Day Moving Average | 2.5 |
| Relative Strength Index (RSI) | 27.59 |
| Average Volume (20 Days) | 1.11M |
Income Statement
In the last 12 months, Shuttle Pharmaceuticals had revenue of $0 and earned -$6.59M in profits. Earnings per share was $-0.41.
| Revenue | 0 |
| Gross Profit | -6.81K |
| Operating Income | -5.89M |
| Net Income | -6.59M |
| EBITDA | -3.99M |
| EBIT | - |
| Earnings Per Share (EPS) | -0.41 |
Balance Sheet
The company has $2.58M in cash and $1.09M in debt, giving a net cash position of $1.49M.
| Cash & Cash Equivalents | 2.58M |
| Total Debt | 1.09M |
| Net Cash | 1.49M |
| Retained Earnings | -25.43M |
| Total Assets | 673.57K |
| Working Capital | -1.30M |
Cash Flow
In the last 12 months, operating cash flow was -$5.58M and capital expenditures -$19.05K, giving a free cash flow of -$5.60M.
| Operating Cash Flow | -5.58M |
| Capital Expenditures | -19.05K |
| Free Cash Flow | -5.60M |
| FCF Per Share | -0.35 |
Margins
Gross margin is 0%, with operating and profit margins of 0% and 0%.
| Gross Margin | 0% |
| Operating Margin | 0% |
| Pretax Margin | 0% |
| Profit Margin | 0% |
| EBITDA Margin | n/a% |
| EBIT Margin | n/a% |
| FCF Margin | n/a% |
Dividends & Yields
SHPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -60.29% |
| FCF Yield | -223.99% |
Analyst Forecast
Currently there are no analyst rating for SHPH.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Aug 13, 2024. It was a backward split with a ratio of 1:8.
| Last Split Date | Aug 13, 2024 |
| Split Type | backward |
| Split Ratio | 1:8 |
Scores
| Altman Z-Score | -106.59 |
| Piotroski F-Score | 4 |